MDG-20XX

N/A

Report date: 2023/09/08 17:41:53

Base Information

Drug NameMDG-20XX

Drug Alias NameMDG-20XXMDG20XX

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators

TargetsGTPase KRas

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedigene Ag

China Registration ClassN/A

Develop Information

Active CompaniesMedigene Ag

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A